Tag:
tesofensine
Latest Headlines
Latest Headlines
NeuroSearch touts Phase II tesofensine data
In a study published in The Lancet, Europe's NeuroSearch announced strong Phase II for tesofensine, the company's anti-obesity compound. The hunger-suppressing drug produced a weight loss twice that
NeuroSearch investors thrill to trial data
Shares of NeuroSearch surged on the news that its obesity drug tesofensine produced very good data in a Phase IIb trial. The drug hit all endpoints with a high statistical significance. One analyst
